GENFIT Stock Euronext Paris
Stocks
GNFT
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Euronext Paris
|
||
| - PTS | - |
|
| Jul. 03 | Genfit soars on news of U.S. reimbursement for a product |  |
| Jul. 03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 707M 0 822M 664M 606M 1.14B 78.17B 1.15B 7.87B 3.06B 39.64B 3.08B 3.02B 131B | P/E 2026 * |
36.5x | P/E 2027 * | 93.9x |
|---|---|---|---|---|---|
| Enterprise Value | 656M 0 762M 616M 562M 1.06B 72.52B 1.06B 7.3B 2.84B 36.77B 2.86B 2.8B 122B | EV / Sales 2026 * |
6.55x | EV / Sales 2027 * | 5.17x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 2019-09-15 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 2021-04-21 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2017-06-15 | |
| Director/Board Member | 54 | 1999-09-14 | |
| Director/Board Member | 58 | 2017-06-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.14% | -1.63% | +1.26% | +18.27% | 49.81B | |
| -1.11% | -2.84% | +420.04% | +505.15% | 44.06B | |
| -0.21% | +0.37% | +36.88% | +17.32% | 42.99B | |
| -1.95% | -3.33% | +8.29% | +73.25% | 40.88B | |
| -0.94% | -1.77% | +18.34% | +46.84% | 33.11B | |
| -1.11% | -4.20% | +25.49% | +119.78% | 16.58B | |
| +6.10% | +4.40% | - | - | 17.27B | |
| +0.77% | -1.30% | +12.53% | +29.10% | 14.63B | |
| -1.12% | -3.46% | +76.50% | +39.37% | 13.76B | |
| Average | +0.07% | -1.37% | +74.92% | +106.13% | 30.34B | |
| Weighted average by Cap. | -0.28% | -1.50% | +88.97% | +122.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 0 116M 94.08M 85.88M 161M 11.07B 162M 1.11B 434M 5.61B 437M 427M 18.59B | 124M 0 144M 116M 106M 200M 13.71B 201M 1.38B 537M 6.95B 541M 529M 23.02B |
| Net income | 22.88M 0 26.57M 21.48M 19.61M 36.84M 2.53B 37.1M 255M 99.04M 1.28B 99.77M 97.6M 4.24B | 6.8M 0 7.9M 6.38M 5.83M 10.95M 751M 11.03M 75.66M 29.44M 381M 29.65M 29.01M 1.26B |
| Net Debt | -51.12M -0 -59.37M -48M -43.81M -82.31M -5.65B -82.9M -569M -221M -2.86B -223M -218M -9.48B | -66.17M -0 -76.86M -62.13M -56.72M -107M -7.31B -107M -736M -286M -3.71B -289M -282M -12.28B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- GNFT Stock
- GNFT Stock
Select your edition
All financial news and data tailored to specific country editions
